Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$696M |
| 2 |
Moderna
MRNA
|
+$487M |
| 3 |
Analog Devices
ADI
|
+$272M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$261M |
| 5 |
Tesla
TSLA
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$670M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$335M |
| 4 |
Alibaba
BABA
|
+$323M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.32% |
| 2 | Healthcare | 13.34% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
3476
Tectonic Therapeutic
TECX
$720M
| $813K | ﹤0.01% |
12,121
+2,358
| +24% | +$194K |
|
3477
Oscar Health
OSCR
$9.5B
| $812K | ﹤0.01% |
46,691
+5,240
| +13% | +$88.9K |
|
|
RTB
3478
RTB Digital
RTB
$226M
| $811K | ﹤0.01% |
280
+110
| +65% | +$369K |
|
3479
Aterian
ATER
$5.26M
| $809K | ﹤0.01% |
6,227
+959
| +18% | +$106K |
|
3480
DoubleVerify
DV
$2.04B
| $809K | ﹤0.01% |
23,679
-17,814
| -43% | -$629K |
|
|
MTEM
3481
DELISTED
Molecular Templates, Inc.
MTEM
| $809K | ﹤0.01% |
8,047
+828
| +11% | +$85.4K |
|
3482
The Honest Company
HNST
$540M
| $807K | ﹤0.01% |
77,790
+12,225
| +19% | +$149K |
|
|
JKS
3483
JinkoSolar
JKS
$860M
| $805K | ﹤0.01% |
17,586
-9,764
| -36% | -$494K |
|
3484
Western New England Bancorp
WNEB
$282M
| $803K | ﹤0.01% |
94,160
-444
| -0.5% | -$3.72K |
|
|
RXDX
3485
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $803K | ﹤0.01% |
33,854
+2,450
| +8% | +$57.8K |
|
3486
Bankwell Financial Group
BWFG
$542M
| $802K | ﹤0.01% |
27,468
+781
| +3% | +$22.7K |
|
|
RDNW
3487
RideNow Group
RDNW
$248M
| $802K | ﹤0.01% |
20,560
+133
| +0.7% | +$4.85K |
|
3488
Zevra Therapeutics
ZVRA
$679M
| $797K | ﹤0.01% |
85,454
+12,809
| +18% | +$129K |
|
|
NMTR
3489
DELISTED
9 Meters Biopharma
NMTR
| $796K | ﹤0.01% |
30,578
+6,501
| +27% | +$153K |
|
3490
Alta Equipment Group
ALTG
$254M
| $795K | ﹤0.01% |
57,893
+3,550
| +7% | +$46.5K |
|
3491
Krispy Kreme
DNUT
$569M
| $795K | ﹤0.01% |
+56,791
| New | +$911K |
|
3492
Establishment Labs
ESTA
$2.25B
| $793K | ﹤0.01% |
11,073
+6,604
| +148% | +$486K |
|
3493
NN Inc
NNBR
$298M
| $792K | ﹤0.01% |
150,876
+7,715
| +5% | +$46.4K |
|
3494
Evolus
EOLS
$536M
| $791K | ﹤0.01% |
103,707
+16,624
| +19% | +$172K |
|
3495
Coca-Cola Femsa
KOF
$23.1B
| $791K | ﹤0.01% |
14,065
+2,216
| +19% | +$124K |
|
3496
Ryan Specialty Holdings
RYAN
$11B
| $789K | ﹤0.01% |
+23,309
| New | +$735K |
|
3497
Eterna Therapeutics
ERNA
$5.16M
| $787K | ﹤0.01% |
11
+1
| +10% | +$86.3K |
|
|
GOOS
3498
Canada Goose Holdings
GOOS
$844M
| $786K | ﹤0.01% |
22,059
-10,437
| -32% | -$416K |
|
|
BCEL
3499
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $783K | ﹤0.01% |
125,690
+35,449
| +39% | +$236K |
|
3500
Culp Inc
CULP
$43.8M
| $780K | ﹤0.01% |
60,492
-600
| -1% | -$8.44K |
|
Similar funds
Bank of New York Mellon's Q3 2021 Portfolio in Review
As of Q3 2021, Bank of New York Mellon held 4,634 positions worth $512B, down 0.89% from $517B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of New York Mellon's Q3 2021 filing shows 243 new, 2,575 increased, 1,388 reduced and 114 closed positions. Its largest new stake was GXO Logistics: 863,863 shares worth $67.8M. The largest sale was Apple, an estimated $670M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2021 buy was GXO Logistics: 863,863 shares worth $67.8M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $696M increase.
- Bank of New York Mellon's biggest Q3 2021 reduction was Apple, cutting an estimated $670M.
- Bank of New York Mellon fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $335M.
- Bank of New York Mellon's ten largest holdings make up 20% of its $512B portfolio in Q3 2021.
- Bank of New York Mellon opened 243 new positions and closed 114 in Q3 2021.
- Bank of New York Mellon's portfolio value fell 0.89% quarter-over-quarter to $512B.
Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.